- Home
- QNRX vs LTRY Comparison
QNRX vs LTRY Comparison
Compare QNRX & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- LTRY
- Stock Information
- Founded
- QNRX 2018
- LTRY 2015
- Country
- QNRX United States
- LTRY United States
- Employees
- QNRX N/A
- LTRY N/A
- Industry
- QNRX Medical/Dental Instruments
- LTRY Computer Software: Prepackaged Software
- Sector
- QNRX Health Care
- LTRY Technology
- Exchange
- QNRX Nasdaq
- LTRY Nasdaq
- Market Cap
- QNRX 5.3M
- LTRY 3.2M
- IPO Year
- QNRX N/A
- LTRY N/A
- Fundamental
- Price
- QNRX $0.70
- LTRY $0.55
- Analyst Decision
- QNRX Strong Buy
- LTRY
- Analyst Count
- QNRX 1
- LTRY 0
- Target Price
- QNRX $4.00
- LTRY N/A
- AVG Volume (30 Days)
- QNRX 1.4M
- LTRY 1.1M
- Earning Date
- QNRX 11-07-2024
- LTRY 12-16-2024
- Dividend Yield
- QNRX N/A
- LTRY N/A
- EPS Growth
- QNRX N/A
- LTRY N/A
- EPS
- QNRX N/A
- LTRY N/A
- Revenue
- QNRX N/A
- LTRY $6,143,350.00
- Revenue This Year
- QNRX N/A
- LTRY N/A
- Revenue Next Year
- QNRX N/A
- LTRY N/A
- P/E Ratio
- QNRX N/A
- LTRY N/A
- Revenue Growth
- QNRX N/A
- LTRY 190.77
- 52 Week Low
- QNRX $0.43
- LTRY $0.22
- 52 Week High
- QNRX $6.18
- LTRY $3.60
- Technical
- Relative Strength Index (RSI)
- QNRX 54.60
- LTRY 67.45
- Support Level
- QNRX $0.47
- LTRY $0.47
- Resistance Level
- QNRX $0.75
- LTRY $0.56
- Average True Range (ATR)
- QNRX 0.10
- LTRY 0.09
- MACD
- QNRX 0.01
- LTRY 0.02
- Stochastic Oscillator
- QNRX 71.51
- LTRY 90.09
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.